Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Successful challenge with the fully human EGFR antibody panitumumab following an infusion reaction with the chimeric EGFR antibody cetuximab.

× No keyword cloud information.

7 in total

1. The escalating role of epidermal growth factor receptor inhibitors in cancer management: clinical considerations for the health system pharmacist.

Authors: Dwight D Kloth; Lew Iacovelli; Rebecca Arbuckle; Angela C McIntosh
Journal: P T Date: 2010-04

2. Different patterns of toxicity after sequential administration of two anti-EGFR monoclonal antibodies.

Authors: Miriam López-Gómez; César Gómez-Raposo; María Sereno; Francisco Zambrana; Enrique Casado
Journal: Clin Transl Oncol Date: 2010-11 Impact factor: 3.405

3. Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis.

Authors: Delphine Mariotte; Benoît Dupont; Radj Gervais; Marie-Pierre Galais; Dominique Laroche; Aurore Tranchant; Elisabeth Comby; Karine Bouhier-Leporrier; Jean-Marie Reimund; Brigitte Le Mauff
Journal: MAbs Date: 2011-07-01 Impact factor: 5.857

4. A case of heterogeneous sensitivity to panitumumab in cetuximab-refractory colorectal adenocarcinoma metastases.

Authors: Eric Marks; Syed Mujtaba Rizvi; Nabeel Sarwani; Zhaohai Yang; Wafik S El-Deiry
Journal: Cancer Biol Ther Date: 2015 Impact factor: 4.742

5. Pro-neoplastic effects of amphiregulin in colorectal carcinogenesis.

Authors: Michael J Guzman; Jinyi Shao; Hongmiao Sheng
Journal: J Gastrointest Cancer Date: 2013-06

6. Safety and efficacy of panitumumab following cetuximab: retrospective review of the Memorial Sloan-Kettering experience.

Authors: Derek G Power; Manish A Shah; Timothy R Asmis; Joaquin J Garcia; Nancy E Kemeny
Journal: Invest New Drugs Date: 2009-05-26 Impact factor: 3.850

7. Ganglioside GM2, highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage.

Authors: Norihiko Sasaki; Kenichi Hirabayashi; Masaki Michishita; Kimimasa Takahashi; Fumio Hasegawa; Fujiya Gomi; Yoko Itakura; Naoya Nakamura; Masashi Toyoda; Toshiyuki Ishiwata
Journal: Sci Rep Date: 2019-12-18 Impact factor: 4.379

7 in total